On November 18, 2020, OMNY Health’s Chief Strategy Officer, Stacey Long, led a discussion with Jared Niedenthal, Head of Rare Disease Insights at UCB, a global biopharma company focused on neurology and immunology, and Christon Hill, VP of Life Cycle Management at BTG...
rare disease
How OMNY Health™ Is Supporting the Fight Against MG
OMNY Health™ worked closely with an innovative pharmaceutical company to support the launch of its Myasthenia Gravis (MG) drug by providing data from two of its health system partners. Compiling in-depth information from more than 30 of our partnered medical...